10.03.2013 • NewsEvonikchemicalschemical industry

Singapore's Temasek to Buy Stake in Germany's Evonik

Singapore state investor Temasek Holdings will take a stake in Evonik Industries, two sources close to one of the German company's owners told Reuters.

Temasek will spend more than €600 million ($779 million) for 5% of the Essen-based chemicals company, which is preparing for a stock market share listing, the sources said on condition that they not be identified.

German magazine Wirtschaftswoche reported on Saturday that Temasek and Evonik had agreed the sale.

A spokesman for Temasek declined to confirm the deal.

The RAG trust, which owns 75% of Evonik, and buyout firm CVC Capital Partners, owner of the rest, said last month that they had placed a small stake with institutional investors as a prelude to an initial public offering (IPO).

Sources close to the matter said that the listing could value the company at €14 billion. Stock market trading of Evonik shares is planned for late April.

Evonik, RAG and CVC all declined to comment on whether a sale to Temasek had been agreed.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.